Long-Term Efficacy of Vedolizumab in Pediatric Inflammatory Bowel Disease

被引：0
|
作者：
Sarles, Harry E., Jr.
Whitney, Annette E.
Kuten, Samantha A.
Van Anglen, Lucinda J.
机构：
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2019年 / 114卷
关键词：
D O I：
10.14309/01.ajg.0000594116.32306.0b
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1147
引用
收藏
页码：S643 / S644
页数：2
相关论文
共 50 条
  • [21] Long-term efficacy of 6-thioguanine in patients with inflammatory bowel disease
    Teml, A
    Dejaco, C
    Miehsler, W
    Harrer, M
    Vogelsang, H
    Reinisch, W
    GASTROENTEROLOGY, 2005, 128 (04) : A587 - A587
  • [22] Favorable impact of long-term exercise on disease symptoms in pediatric patients with inflammatory bowel disease
    Legeret, Corinne
    Mahlmann, Laura
    Gerber, Markus
    Kalak, Nadeem
    Kohler, Henrik
    Holsboer-Trachsler, Edith
    Brand, Serge
    Furlano, Raoul
    BMC PEDIATRICS, 2019, 19 (01)
  • [23] Favorable impact of long-term exercise on disease symptoms in pediatric patients with inflammatory bowel disease
    Corinne Legeret
    Laura Mählmann
    Markus Gerber
    Nadeem Kalak
    Henrik Köhler
    Edith Holsboer-Trachsler
    Serge Brand
    Raoul Furlano
    BMC Pediatrics, 19
  • [24] The Use of Vedolizumab for Treatment of Severe Pediatric Inflammatory Bowel Disease
    Conrad, Maire A.
    Stein, Ronen
    Maxwell, Elizabeth C.
    Albenberg, Lindsey
    Baldassano, Robert
    Grossman, Andrew B.
    Mamula, Petar
    Piccoli, David
    Kelsen, Judith R.
    GASTROENTEROLOGY, 2015, 148 (04) : S72 - S72
  • [25] Real World Experience of Vedolizumab in Pediatric Inflammatory Bowel Disease
    Whitney, Annette
    Sarles, Harry E., Jr.
    Claudia, Schroeder P.
    Okoro, Tracy C.
    Van Anglen, Lucinda J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S396 - S396
  • [26] ANTI-TNF EFFICACY AFTER PRIMARY VEDOLIZUMAB FAILURE IN PEDIATRIC INFLAMMATORY BOWEL DISEASE
    Dolinger, Michael
    Rolfes, Priya
    Phan, Becky
    Pan, Stephanie
    Dubinsky, Marla
    INFLAMMATORY BOWEL DISEASES, 2020, 26 : S71 - S72
  • [27] REAL-WORLD SAFETY AND EFFICACY OF USTEKINUMAB AND VEDOLIZUMAB IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Hsu, Diane
    Lee, Justin
    Kotzen, Alison Borrman
    Bensen, Rachel
    Goyal, Alka
    GASTROENTEROLOGY, 2024, 166 (05) : S1210 - S1211
  • [28] REAL-WORLD SAFETY AND EFFICACY OF USTEKINUMAB AND VEDOLIZUMAB IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Hsu, Diane
    Lee, Justin
    Kotzen, Alison
    Bensen, Rachel
    Goyal, Alka
    GASTROENTEROLOGY, 2024, 166 (03) : S101 - S102
  • [29] ITALIAN REAL-LIFE STUDY EVALUATING THE LONG-TERM EFFECTIVENESS OF VEDOLIZUMAB FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE
    Pugliese, D.
    Privitera, G.
    Armuzzi, A.
    DIGESTIVE AND LIVER DISEASE, 2023, 55 : S113 - S114
  • [30] VEDOLIZUMAB LEVELS DURING INDUCTION ARE ASSOCIATED WITH LONG-TERM CLINICAL AND ENDOSCOPIC REMISSION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Yarur, Andres J.
    Bruss, Alexandra
    Berens, Brandon
    Fox, Caroline
    Beniwal-Patel, Poonam M.
    Patel, Amir
    Ungaro, Ryan C.
    Dubinsky, Marla
    Naik, Snehal
    Stein, Daniel J.
    GASTROENTEROLOGY, 2018, 154 (06) : S827 - S828
12345